Cambridge Healthtech Institute’s 8th Annual

Bioproduction: Scale, Bioreactors & Disposables

Making It Work

August 15-16, 2018


The 8th annual “Bioproduction” conference examines biologics production, including scale-down models, scaling up production, engineering bioreactors, single-use systems, and ensuring quality, within the context of increasing productivity. A holistic review of bioprocessing will be explored, as well as practical details, such as monitoring and analyzing processes, and looking in-depth into how bioreactors process cells. The conference will address robust manufacturing processes and next-generation technologies, while improving manufacturing platforms and ensuring product quality.


Preliminary Agenda


BIOPRODUCTION STRATEGIES

KEYNOTE PRESENTATION:

Next-Generation Biomanufacturing Processes and the Use of Integrated Advanced Process Control Tools

Anne Tolstrup, PhD, Senior Manager, Manufacturing Sciences, Cell Culture, Biogen (Denmark) Manufacturing ApS

Phase-Appropriate GMP for Biologicals Manufacturing – What Does It Mean and How Should It Be Interpreted?

Trevor Deeks, PhD, QA and QC Consultant at Teva Biopharmaceuticals USA, Inc., and Consultant, Deeks Pharmaceutical Consulting Services LLC


PROCESS DEVELOPMENT & INTENSIFICATION

Process Intensification: Current Approaches and Future Strategies

Stefan Schmidt, PhD, MBA, Head, Operations, Production, Lonza/Sanofi JV


SCALING UP PRODUCTION

FEATURED PRESENTATION:

Application of Computational Fluid Dynamics for Characterization of Parameters Impacting Scale-Up of Monoclonal Antibody Production Processes

Michelle LaFond, Senior Director, Bioreactor Scale-Up and Development, Regeneron Pharmaceuticals, Inc.


DISPOSABLE TECHNOLOGIES

Application of Alternative Cell Separation Systems for the Harvest of Mammalian Cell Culture Processes in a Fully Disposable Single-Use Facility

Dominique T. Monteil, PhD, Scientist II, Cell Culture, Process Science, Boehringer Ingelheim Fremont, Inc.


BIOREACTOR ENGINEERING & EQUIPMENT CHARACTERIZATION

Implementing a Mini-Bioreactor in an End-to-End Automation Fashion

Xiaoyan Tang, MD, Senior Scientist, Cell Line Development, Merck & Co., Inc.

Equipment Characterization of a New Biologics Facility -- Lessons Learned

Jose Vallejos, PhD, Manufacturing Scientist, MS&T, AstraZeneca




For more details on the conference, please contact:
Mary Ruberry
Senior Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421
Email: mruberry@healthtech.com


For partnering and sponsorship information, please contact:

Companies A-K

Sherry Johnson
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: 781-972-1359
Email: sjohnson@healthtech.com

Companies L-Z

Carolyn Benton
Business Development Manager
Cambridge Healthtech Institute
Phone: 781-972-5412
Email: cbenton@healthtech.com


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Premier Sponsors:

Millipore Sigma
Unchained Labs